Clinical Data on Transdermal CBD Gel Safety in Fragile X
Comments Off on Clinical Data on Transdermal CBD Gel Safety in Fragile X
April 15, 2026
Transdermal cannabidiol gel safety is being studied in children and adolescents with Fragile X syndrome. Clinical data from ongoing trials evaluate the tolerability of synthetic CBD delivered through the skin. These results provide insight into the…
Cannabinoid Clinical Trials: CBD Gel Safety in Fragile X
Comments Off on Cannabinoid Clinical Trials: CBD Gel Safety in Fragile X
March 4, 2026
Transdermal cannabidiol gel fragile x syndrome safety data comes from ongoing clinical trials evaluating long-term tolerability in children and adolescents. This synthetic CBD formulation targets behavioral symptoms linked to endocannabinoid…